Status:
COMPLETED
Functional MRI Changes Resulting From the Feuerstein Program in Older People With Mild Cognitive Impairment (MCI)
Lead Sponsor:
Rambam Health Care Campus
Collaborating Sponsors:
Adolf und Mary Mil-Stiftung
Helen Bader Foundation
Conditions:
Mild Cognitive Impairment
Eligibility:
All Genders
60+ years
Phase:
NA
Brief Summary
Background: The Feuerstein Instrumental Enrichment Program was designed to prevent mental deterioration and preserve cognitive abilities among people aged 60 and above. The program is an applied pract...
Detailed Description
Introduction In recent decades, with the increase in life expectancy, the number of older people and their relative rate within the population have risen dramatically. This trend led to increased rat...
Eligibility Criteria
Inclusion
- Aged 60 and above.
- Hebrew speakers.
- Expressing willingness to participate in the research and deliberately signing a consent form.
- A diagnosis of MCI exists according to accepted clinical criteria - the examinee's score in the MoCA Test is within the range of 18-26 (inclusive).
Exclusion
- A medical or functional condition that will not allow the subject to participate in the intervention program within the research period.
- Diagnosed subjects suffering from active depression, bipolar disorder or schizophrenia.
- Subjects who suffer from a diagnosed cognitive impairment other than MCI (delirium dementia or mental retardation).
- Visual impairment that will not allow subjects to observe detailed information on a 32' screen from a distance of 1 meter.
- Hearing impairment that will not allow subjects to listen to instructions during assessment.
- Subjects whose MoCA Test's score is 17 and below or 27 and above.
- Subjects unable to undergo MRI assessments based on a standard questionnaire of eligibility for MRI excluding the use of metal and electronic implants.
- Subjects who will decide not to participate following a 10 minute MRI scan which will allow subjects to experience the procedure.
- The finding of a Random Space Occupying Lesion on MRI scan at initial anatomical assessment.
Key Trial Info
Start Date :
July 4 2017
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
June 28 2019
Estimated Enrollment :
28 Patients enrolled
Trial Details
Trial ID
NCT03447236
Start Date
July 4 2017
End Date
June 28 2019
Last Update
September 17 2019
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Rambam Health Care Campus
Haifa, Israel, 3109601